To do today: (1) write, (2) blog, (3) clean up desk.
But instead I'll artfully arrange the desktop clutter to catch a slice of life and kill two birds with one stone. It's my desk and a blog post.
Here's my work space. It features research material, photos I meant to put in an album two years ago, and DVDs I plan to watch. Also: the promotional brochure for the German editions of the Evan Delaney series, and the upcoming American cover of China Lake.
The Germans call Evan the "neue Heldin" and "eine Powerfrau." Gotta say, I love that.
Blimey! I mentioned before how The Age of Conversation was so reading there wasn't the slightest bit of doubt, want to be part of this again. And so I am :) Thanks Drew, thanks !
That dates from a few days ago already and I didn't have time yet to extend the call out for authors on this new AOC project, but here it is. I think it's not too late yet, but I you want in then be quick about it. Trust me, you won't regret, The Age of Conversation is one of these experiences you won't likely forget. !
Civil Aviation: Standards and Liabilities is a new work, providing practical guidance and advice on how to navigate the complicated legislative structure surrounding civil aviation. Looking at the operational standards and obligations in civil aviation and the consequences of failure to comply with them, it is an essential reference guide for dealing with the many problems that arise.
The book examines the main structures of civil aviation legislation including The Functioning of ICAO and The ICAO Montreal Convention 1999.
Experienced lawyers specialising in this area will find it an essential everyday reference tool, whilst non-legal professionals including government regulators, insurers, insurance brokers, airlines, airports, manufacturers and administrators will use it as an introduction to this complex industry.
Oh, bliss! I became exhausted always worrying about work and studying to improve my skills. I decided I was going to take some time and feed my brain things to make it happy. I decadently ordered 4 books from Amazon (4 for 3 plus Super Saver Shipping = $21). Two were Sharon Shinn books and two were Lee & Miller. Unlike sometimes with Super Saver Shipping, they arrived immediately. I spent a delightful evening immersing myself in Shinn's Safe-Keeper.
As always, Shinn starts with an interesting premise. In a bucolic world, there are three trades of people with special, sometimes magical, talents. The Safe-Keepers keep secrets. What happens if someone tells a dark secret? Is the role of the Safe-Keeper just to listen and provide relief to the teller by letting them not bear their secret alone? If someone is being hurt, should the Safe-Keeper intervene? How can she take action without revealing the secret? The Truth-Tellers tell truth, even -especially - if people don't want to hear it. The Truth-Tellers don't know everything, but sometimes the truth is magically revealed to them. The Truth-Tellers aren't too popular, because truth can be uncomfortable. The Dream-Makers can sometimes channel magic to make people's dreams come true. Everyone cherishes the dream-makers. A Dream-Maker's own life is tragic and hard to bear, but they gain some comfort by watching other people made happy through their magic. The story is that on the night that the Safe-Keeper gives birth to a child of unknown paternity, a mysterious rider comes to her door and leaves her with another baby and a secret. What happens to the babies and their secrets? Read the book to find out.
I read that the Safe-Keeper series is written for teenagers. I suppose that is so. The book is not long - I read it in three hours. The tone of the book is fairly calm. The emotional conflicts aren't too conflicted. I did cry during one sad part of the book.
What role would I play if I existed in the book? Definitely a Truth-Teller - uncomfortable and unsubtle. I'm not a quiet, listening, sympathizing Safe-Keeper. I'm definitely not a tragic but joy-giving Dream-Maker.
Sharon Shinn - Thank you for a very enjoyable evening and some interesting ideas to muse over!
In a matter of few days I will be moving into a . This also means that I have to get rid of a lot of things ... unwanted books, appliances, woodworks, artworks, gadgets, furnitures and a million more things so that I can fit into that small place.
I was checking out the stuff I got to get rid off... and maan! I was surprised at the amount of junk I had stacked in the past four years. If you want anything starting from Harry Potter books to advanced calculus to teach yourself SQL server in 24 hours to electronic circuits and devices by Boylestad to how to draw hentai to stepper motors to broken phones to wasted circuit boards to two lts. of copper sulphate solution to GRE prep material to 2894 end game dominations in chess to a million more things, just let me know asap. Will give it to you for free.
Anybody has any bright idea on how can I get rid of all these stuff quickly? The junk store is a good option, but I don't want these pretty valuable things to go to waste.
I started a new book called "The Alchemist" by Paulo Coleho. -- I've had this book for years collecting dust on my shelves. I've seen it over and over promoted in bookstores especially Barnes & Noble and have had friends that read it. I know it's about spirituality and I was in the mood for a dose of that so I decided to give it another shot. It's a very thin book and a real quick read but I just came across a story in the book I wanted to share. It pounded in my unconsciousness as I dreamed.
It was about a shopkeeper who sent his son out to learn the true meaning of happiness. So he sent him to a wise man far away. The wise man was very busy with lots of people talking to him. When the boy finally got a chance to speak to the wise man the wise man gave him a teaspoon with two drops of oil in it. He told the boy to see his beautiful palace and come back to him but not to drop any of the oil in the spoon. So the boy went around the palace and returned. When the wise man asked him what the boy thought of his beautiful palace the book said in shame he did not see because he was so focused on not spilling the oil in the spoon. The wise man said that's no good and to return and see his beautiful palace and enjoy himself. So the boy returned with a wide smile after seeing the beautiful palace. The wise man asked what happened to the oil in the spoon and the boy looked at the spoon without oil and said he must have spilled it. The wise man said the key to happiness is seeing the world and everything beautiful without spilling the oil in the spoon.
At first my minds instinctive reaction was like "WHAT?". Then I realized that the oil signified your responsibilities in life and the palace your leisure in life. Both equally important. One must enjoy life but be mindful of his responsibilities. May it be family, loved ones, career, education etc. Perhaps we may not always enjoy securing the oil in the spoon but it is our task to do sometimes what we have to in order to properly enjoy life.
When I first finished the story, too, I imagined myself with a maniacal look spilling all the oil on purpose and abandoning all of my responsibilities in life then tossing the spoon away and sitting in the sun to enjoy the palace.
That's where my err is and my redemption is more clear.
4 Key Questions to Ask Before Your Next Career Move by Dick Richards
Don Blohowiak "This is a pleasant read with potentially profound implications for people who avail themselves of its wisdom."
Kevin Eikenberry ( The content is fantastic. The writing style is approachable and includes stories I can relate to and that illustrate the points very well. The layout if the book is outstanding - there are helpful illustrations and plenty of room for notes - an important consideration for a book like this. Above these tangible dimensions, the feeling I get when reading is book is positive. The author cares about his readers and it shows in every part of this book.
I recommend this book highly for anyone - not just those in a career assessment or transition situation.
But this book is one that I can wholeheartedly recommend. If you actually work through all the exercises (and none are very difficult), I think you'll achieve a greater level of clarity. I think this book would be especially great for people in their 20s who are still uncertain about the right career for them.
A Crow was sitting on a branch of a tree with a piece of cheese in her beak when a Fox observed her and set his wits to work to discover some way of getting the cheese. Coming and standing under the tree he looked up and said, "What a noble bird I see above me! Her beauty is without equal, the hue of her plumage exquisite. If only her voice is as sweet as her looks are fair, she ought without doubt to be Queen of the Birds."
The Crow was hugely flattered by this, and just to show the Fox that she could sing she gave a loud caw. Down came the cheese, of course, and the Fox, snatching it up, said, "You have a voice, madam, I see: what you want is wits."
Perched on a lofty oak,
Sir Raven held a lunch of cheese;
Sir Fox, who smelt it in the breeze,
Thus to the holder spoke:
"Ha! how do you do, Sir Raven?
>>>
........................................................................................................................................
This goes to show how much translations differ from each other in everything, except that they all sound old.
Insulin Delivery Systems Market Analysis (2007-2010)
The research report “Insulin Delivery Systems Market Analysis (2007-2010)” gives an exhaustive analysis on the global insulin market and various Insulin delivery methods. The report investigates the market for various devices used for delivering insulin, including syringes, pens, pumps, needle-free injectors and inhalers. It also takes into account pros and cons of each device and gives a detailed analysis on their future prospects.
The insulin market, driven by the increasing prevalence of diabetes, is presently witnessing robust double-digit growth, thus pushing strong demand for insulin delivery devices. Most of the insulin today is available in injectable form through syringes, pens, pumps and needle-free devices, however, the pain and inconvenience of most of these devices are driving pharmaceutical companies to discover other ‘painless’ modes of insulin delivery, particularly oral methods.
In the search for introducing painless devices, Exubera, the first inhalable insulin, was launched by Pfizer in 2006. However, the device failed to create any major impact and received only a fraction of prescriptions before the company finally decided to stop selling it in 2007. A similar fate is expected for other inhalable insulin. Nevertheless, the market for insulin continues to be immensely lucrative with around 380 Million people having diabetes by 2025, driving drug companies to continue to eye this market which will always be a good bet.
Key Findings
The insulin market is expected to witness double-digit growth during 2007-2012.
By 2025, nearly one-third of total diabetes patients will be from India and China and both have relatively nascent but emerging insulin markets.
Insulin syringes and pumps dominate the US market.
Majority of users in Europe and Japan continue to use pen devices.
Needle-free injectors have been launched in the market decades ago, but so far, have failed to create a major impact.
Exubera, the first inhalable insulin, which was earlier thought to be a billion dollar blockbuster, turned out to be one of the biggest flops in pharmaceutical history.
Key Issues & Facts Analyzed
Evaluation of past, current and future market trends
Discussion about the modes of insulin delivery
A detailed analysis of the major insulin delivery devices
Analysis of pros and cons of major insulin devices
Scope of the major insulin delivery systems all over the world
Analysis of various challenges and opportunities for the industry
Profile discussion of key players in the sector
Key Players Analyzed
This section provides the overview, key facts and financial information of prominent players in the global insulin delivery market like Eli Lilly & Company, Novo Nordisk A/S, Sanofi-Aventis, Becton Dickinson & Company and Medtronic Inc.
Research Methodology Used
Information Sources
Information has been sourced from various sources like books, newspapers, trade journals, and white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases.
Analysis Methods
The analysis methods include ratio analysis, historical trend analysis, linear regression analysis using software tools, judgmental forecasting, and cause and effect analysis.
Table of Content
1. Analyst View
2. Diabetes Disease Indicator
3. Diabetes & Obesity
4. Global Market Analysis
4.1 Global Diabetes Drugs Market
4.2 Global Insulin Market
4.2.1 India
4.2.1.1 Prevalence
4.2.1.2 Market Analysis
4.2.2 China
4.2.2.1 Prevalence
4.2.2.2 Market Analysis
4.2.3 US
4.2.3.1 Prevalence
4.2.3.2 Market Analysis
4.2.4 Russia
4.2.4.1 Prevalence
4.2.4.2 Market Analysis
4.2.5 Japan
4.2.5.1 Prevalence
4.2.5.2 Market A+G1nalysis
4.2.6 Germany
4.2.6.1 Prevalence
4.2.6.2 Market Analysis
4.2.7 Pakistan
4.2.7.1 Prevalence
4.2.7.2 Market Analysis
4.2.8 Brazil
4.2.8.1 Prevalence
4.2.8.2 Market Analysis
4.2.9 Mexico
4.2.9.1 Prevalence
4.2.10 Egypt
4.2.10.1 Prevalence
5. Insulin Delivery Devices
5.1 Present Devices
5.1.1 Insulin Pens
5.1.1.1 Mechanism & Technologies
5.1.1.2 Market Analysis
5.1.1.2.1 Global
5.1.1.2.2 US
5.1.1.2.3 Europe
5.1.1.2.4 Japan
5.1.1.3 Pros & Cons
5.1.1.4 Key Players
5.1.2 Insulin Pumps
5.1.2.1 Mechanism & Technologies
5.1.2.2 Market Analysis
5.1.2.2.1 Global
5.1.2.2.2 US
5.1.2.2.3 Non US
5.1.2.3 Pros & Cons
5.1.2.4 Key Players
5.1.3 Inhaled Insulin
5.1.3.1 Mechanism & Technologies
5.1.3.2 Market Analysis
5.1.3.2.1 Exubera Lackluster Performance
5.1.3.2.2 Why Exubera Failed?
5.1.3.2.2.1 Poor Preparation for Product Launching
5.1.3.2.2.2 Insurance Reimbursements
5.1.3.2.2.3 Lack of Market Understanding for this Product
5.1.3.2.2.4 Effectiveness of Other Diabetes Treatments
5.1.3.2.2.5 Lack of Safety Data & Health-related Problems
5.1.3.2.2.6 Poor Design & Other Inconveniences
5.1.3.3 Pros & Cons
5.1.3.4 Projections & Future of Other Inhalable Insulin
5.1.4 Insulin Syringes
5.1.4.1 Mechanism & Technology
5.1.4.2 Market Analysis
5.1.4.3 Pros & Cons
5.1.4.4 Future Outlook (2007-2010)
5.1.5 Insulin Jet Injectors
5.1.5.1 Mechanism & Technologies
5.1.5.2 Market Analysis
5.1.5.3 Pros & Cons
5.1.5.4 Future Outlook (2007-2010)
5.2 Future Devices
5.2.1 Oral Insulin
5.2.2 Insulin Patch
5.2.3 Implantable Insulin Pumps
6. Industry Analysis
6.1 Drivers
6.1.1 Increasing Number of Diabetic Patients
6.1.2 Convenient & Less Painful Modes of Insulin Delivery
6.1.3 Improved Access & Lower Insulin Prices in the Developing World
6.1.4 Early Diagnosis & Increasing Awareness for Treatment
6.1.5 Government Support
6.2 Challenges
6.2.1 High R&D & Production Cost
6.2.2 Long Time to Market
6.2.3 Poverty
6.2.4 Insurance Reimbursement
6.2.5 Traditional Treatments
6.2.6 High Cost of Insulin Inhalers
6.2.7 Rapidly Changing Technology
6.3 Opportunities
6.3.1 US & Developing Countries - Potential Markets for Insulin Syringes
6.3.2 Europe & Japan - Potential Markets for Pen Devices
6.3.3 Developed World - Potential Market Oral Insulin
6.3.4 US - Potential Market for Insulin Pumps
7. Future Outlook
7.1 Global Diabetes Drug Market (2007-2012)
8. Key Players
8.1 Eli Lilly & Company
8.2 Novo Nordisk A/S
8.3 Sanofi-Aventis
8.4 Becton, Dickinson and Company
8.5 Medtronic, Inc.
List of Table
Table 2-1: Global - Top 10 Countries with Maximum Diabetic Population in Age Group 20-79 Years (in Million), 2003 & 2025F
Table 3-1: Global - Percentage of Overweight Population by Leading Countries (2006)
Table 3-2: Global - Percentage of Diabetic Population by Leading Countries (2003)
Table 4-1: Global - List of Top 10 Anti-diabetic Brands, 2005
Table 4-2: India - Diabetic Patients in Age Group 20-79 Years (in ‘000), 2003
Table 4-3: India - Forecast for Diabetic Patients in Age Group 20-79 Years (in ‘000), 2025
Table 4-4: China - Diabetic Patients in Age Group 20-79 Years (in '000), 2003
Table 4-5: China - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2025
Table 4-6: US - Diabetic Patients in Age Group 20-79 Years (in '000), 2003
Table 4-7: US - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2025
Table 4-8: Russia - Diabetic Patients in Age Group 20-79 Years (in '000), 2003
Table 4-9: Russia - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2025
Table 4-10: Japan - Diabetic Patients in Age Group 20-79 Years (in '000), 2003
Table 4-11: Japan - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2025
Table 4-12: Germany - Diabetic Patients in Age Group 20-79 Years (in '000), 2003
Table 4-13: Germany - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2025
Table 4-14: Pakistan - Diabetic Patients in Age Group 20-79 Years (in '000), 2003
Table 4-15: Pakistan - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2025
Table 4-16: Brazil - Diabetic Patients in Age Group 20-79 Years (in '000), 2003
Table 4-17: Brazil - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2025
Table 4-18: Mexico - Diabetic Patients in Age Group 20-79 Years (in '000), 2003
Table 4-19: Mexico - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2025
Table 4-20: Egypt - Diabetic Patients in Age Group 20-79 Years (in '000), 2003
Table 4-21: Egypt - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2025
Table 5-1: Characteristics of Various Inhalable Insulin Products
Table 8-1: Eli Lilly & Company - Key Financials (in Million US$), 2004-2006
Table 8-2: Novo Nordisk A/S - Key Financials (in Million US$), 2004-2006
Table 8-3: Sanofi-Aventis - Key Financials (in Million US$), 2004-2006
Table 8-4: Becton, Dickinson and Company - Key Financials (in Million US$), 2005-2007
Table 8-5: Medtronic, Inc. - Key Financials (in Million US$), 2005-2007
List of Charts
Figure 3-1: Global - Overweight & Obese Population (in Billion), 2005, 2007E & 2015E
Figure 4-1: Global - Number of Diabetic Patients (in Million), 2003 & 2007
Figure 4-2: Global - Diabetes Drugs Market (in Billion US$), 2004-2006
Figure 4-3: Global - Insulin Market (in Billion US$), 2005 & 2006
Figure 4-4: India - Diabetic Patients in Age Group 20-79 Years (in '000), 2003-2006E
Figure 4-5: India - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2007, 2013, 2019 & 2025
Figure 4-6: India - Insulin Market (in Billion INR), 2003 & 2006
Figure 4-7: India - Share of Key Players in Insulin Market (%), 2004
Figure 4-8: China - Diabetic Patients in Age Group 20-79 Years (in '000), 2003-2006E
Figure 4-9: China - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2007, 2013, 2019 & 2025
Figure 4-10: China - Insulin Market (in Billion RMB), 2005, 2006E & 2012F
Figure 4-11: China - Share of Key Players in Insulin Market (%), 2004*
Figure 4-12: US - Diabetic Patients in Age Group 20-79 Years (in ‘000), 2003-2006E
Figure 4-13: US - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2007, 2013, 2019 & 2025
Figure 4-14: US - Insulin Market (in Billion US$), 2003-2006E
Figure 4-15: US - Share of Key Players in Insulin Market (%), 2006
Figure 4-16: Russia - Diabetic Patients in Age Group 20-79 Years (in '000), 2003-2006E
Figure 4-17: Russia - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2007, 2013, 2019 & 2025
Figure 4-18: Russia - Insulin Market (in Million US$), 2005-2008E
Figure 4-19: Russia - Share of Key Players in Insulin Market (%), 2005
Figure 4-20: Russia - Share of Sales Channel in Insulin Market (%), 2005
Figure 4-21: Japan - Diabetic Patients in Age Group 20-79 Years (in '000), 2003-2006E
Figure 4-22: Japan - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2007, 2013, 2019 & 2025
Figure 4-23: Japan - Insulin Market (in Billion JPY), 2004-2006E & 2012F
Figure 4-24: Japan - Share of Novo Nordisk in Insulin Market (%), 2006*
Figure 4-25: Germany - Diabetic Patients in Age Group 20-79 Years (in '000), 2003-2006E
Figure 4-26: Germany - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2007, 2013, 2019 & 2025
Figure 4-27: Germany - Insulin Market (in Billion US$), 2005-2007E
Figure 4-28: Pakistan - Diabetic Patients in Age Group 20-79 Years (in '000), 2003-2006E
Figure 4-29: Pakistan - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2007, 2013, 2019 & 2025
Figure 4-30: Brazil - Diabetic Patients in Age Group 20-79 Years (in '000), 2003-2006E
Figure 4-31: Brazil - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2007, 2013, 2019 & 2025
Figure 4-32: Brazil - Insulin Market (in Million US$), 2000E, 2006 & 2010E
Figure 4-33: Mexico - Diabetic Patients in Age Group 20-79 Years (in '000), 2003-2006E
Figure 4-34: Mexico - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2007, 2013, 2019 & 2025
Figure 4-35: Egypt - Diabetic Patients in Age Group 20-79 Years (in '000), 2003-2006E
Figure 4-36: Egypt - Forecast for Diabetic Patients in Age Group 20-79 Years (in '000), 2007, 2013, 2019 & 2025
Figure 5-1: Global, US, Europe & Japan - Insulin Units Delivered through Pen Devices (%), 2006
Figure 5-2: US - Insulin Pen Devices Market (in Million US$), 2003-2006E
Figure 5-3: US - Insulin Pen Devices Market (in Million US$), 2007-2010F
Figure 5-4: US - Insulin Units Delivered through Pen Devices (%), 1996, 2000, 2004 & 2006
Figure 5-5: US - Volume Share of Disposable & Refillable Pen Devices (%), 2006
Figure 5-6: Europe - Insulin Units Delivered through Pen Devices (%), 1996, 2000, 2004 & 2006
Figure 5-7: Europe - Volume Share of Disposable & Refillable Pen Devices (%), 2006
Figure 5-8: Japan - Insulin Units Delivered through Pen Devices (%), 1996, 2000, 2004 & 2006
Figure 5-9: Global - Share of Key Players in Pen Devices Market (%), 2005
Figure 5-10: Global - Insulin Pumps & Disposables Market (in Million US$), 2002-2006E
Figure 5-11: Global - Insulin Pumps & Disposables Market (in Million US$), 2007-2009F
Figure 5-12: Global - Share of US & Non-US Markets in Insulin Pumps & Disposables Market (%), 2002-2006E
Figure 5-13: Global - Share of US & Non-US Markets in Insulin Pumps & Disposables Market (%), 2007-2009F
Figure 5-14: US - Insulin Pumps & Disposables Market (in Million US$), 2002-2006E
Figure 5-15: US - Insulin Pumps & Disposables Market (in Million US$), 2007-2009F
Figure 5-16: US - Share of Insulin Pumps & Disposables in Market (%), 2002-2006E
Figure 5-17: US - Share of Insulin Pumps & Disposables in Market (%), 2007-2009F
Figure 5-18: US - Sales of Insulin Pumps (in ‘000 Units), 2002-2006E
Figure 5-19: US - Sales of Insulin Pumps (in ‘000 Units), 2007-2009F
Figure 5-20: US - Sales of New & Replacement Insulin Pumps (in ‘000 Units), 2002-2006E
Figure 5-21: US - Sales of New & Replacement Insulin Pumps (in ‘000 Units), 2007-2009F
Figure 5-22: US - Cumulative Sales of New Insulin Pumps (in ‘000 Units) 2007-2009F
Figure 5-23: US - Cumulative Sales of New Insulin Pumps for Type 1 & Type 2 Patients (in ‘000 Units), 2002-2006E
Figure 5-24: US - Cumulative Sales of New Insulin Pumps for Type 1 & Type 2 Patients (in ‘000 Units), 2007-2009F
Figure 5-25: US - Cumulative Penetration of Type 1 & Type 2 Patients using Insulin Pumps (%), 2002-2006E
Figure 5-26: US - Cumulative Penetration of Type 1 & Type 2 Patients using Insulin Pumps (%), 2007-2009F
Figure 5-27: US - Users Discontinuing Use of Insulin Pumps (%), 2002-2006E
Figure 5-28: US - Users Discontinuing Use of Insulin Pumps (%), 2007-2009F
Figure 5-29: Non-US - Insulin Pumps & Disposables Market (in Million US$), 2002-2006E
Figure 5-30: Non-US - Insulin Pumps & Disposables Market (in Million US$), 2007-2009F
Figure 5-31: Global - Share of Key Players in Insulin Pumps Market (%), 2002-2006E
Figure 5-32: Global - Share of Key Players in Insulin Pumps Market (%), 2007-2009F
Figure 5-33: US - Share of Key Players in Insulin Pumps Market (%), 2002-2006E
Figure 5-34: US - Share of Key Players in Insulin Pumps Market (%), 2007-2009F
Figure 5-35: Europe - Share of Key Players in Insulin Pumps Market (%), 2004
Figure 5-36: Japan - Share of Nipro in Insulin Pumps Market (%), 2005
Figure 5-37: Global - Sales of Exubera (in Million US$), 2006*, 2007** & 2015F
Figure 5-38: Global - Forecast for Sales of Exubera, Technosphere, Air System & Aerx-iDMS (in Million US$), 2015
Figure 5-39: Global - Forecast for Share of Inhalable Insulin (%), 2015
Figure 5-40: US - Insulin Syringes Market (in Million US$), 2003-2006E
Figure 5-41: US - Share of Insulin Syringes Market (%), 2003-2006E
Figure 5-42: US - Forecast for Insulin Syringes Market (in Million US$), 2007-2010
Figure 5-43: US - Forecast for Share of Insulin Syringes Market (%), 2007-2010
Figure 5-44: Global - Jet Injectors & Insulin-driven Jet Injectors Market (in Million US$), 2003-2006E
Figure 5-45: US - Insulin-driven Jet Injectors Market (in Million US$), 2003-2006E
Figure 5-46: US - Share of Insulin-driven Jet Injectors Market (%), 2003-2006E
Figure 5-47: Global - Forecast for Insulin-driven Jet Injectors Market (in Million US$), 2007-2010
Figure 5-48: US - Forecast for Insulin-driven Jet Injectors Market (in Million US$), 2007-2010
Figure 5-49: US - Forecast for Share of Insulin-driven Jet Injectors Market (%), 2007-2010
Figure 7-1: Global - Forecast for Number of Diabetic Patients (in Million), 2013, 2019 & 2025
Figure 7-2: Global - Forecast for Diabetes Drugs Market (in Billion US$), 2007-2012
Figure 7-3: Global - Forecast for Insulin Market (in Billion US$), 2007-2012
Figure 7-4: Global - Insulin Demand (in Kg), 2006 & 2012F
